Most Read Articles
6 days ago
Older women with longer endogenous oestrogen exposure and hormone therapy use are at much higher odds of having favourable cognitive status in late life, a recent study suggests.
3 days ago
In patients with atrial fibrillation (AF) and stable coronary artery disease (CAD), rivaroxaban monotherapy is noninferior to combination treatment with an antiplatelet therapy in terms of cutting the risk of cardiovascular events and mortality, according to data from the AFIRE trial.
Elvira Manzano, 4 days ago
Supplementation with omega-3 fatty acids or vitamin D3 for up to 5 years has no effect on kidney function in adults with type 2 diabetes (T2D), the VITAL-DKD* ancillary study has shown.
Jairia Dela Cruz, 2 days ago
Many patients with nonvalvular atrial fibrillation (NVAF) in Thailand use anticoagulants, but the uptake of nonvitamin-K oral anticoagulants remains suboptimal despite showing an upward trend, according to data from the COOL-AF registry presented at the European Society of Cardioloy (ESC) Asia Congress 2019 with APSC and AFC.

Female sex linked to poor survival outcomes after radical cystectomy for bladder cancer

19 Mar 2018

Women who undergo radical cystectomy for bladder cancer are more likely to have worse outcomes, including disease-free survival (DFS), cancer-specific survival (CSS) and overall survival (OS), compared with their male counterparts, a study reports.

Researchers conducted a systematic review and meta-analysis of studies evaluating gender-specific differences in DFS, CSS or OS following radical cystectomy in bladder cancer patients. Random effect meta-analysis, subgroup analyses, meta-influence and cumulative meta-analyses were used. Funnel plot and Egger´s test facilitated assessment of publication bias.

A total of 3,868 studies were identified during literature search, of which 59 were included in the analysis. There were 30 studies (n=38,321) that evaluated DFS, 44 studies (n=69,666) that evaluated CSS and 26 studies (n=30,039) that evaluated OS.

Pooled data revealed that DFS, CSS and OS were less favourable in female vs male patients, with respective hazard ratios of 1.16 (95 percent CI, 1.06–1.27; p=0.0018), 1.23 (1.15–1.31; p<0.001) and 1.08 (1.03–1.12; p=0.0004). Subgroup analyses confirmed worse DFS, CSS and OS in female patients in all strata.

Studies evaluating CSS showed publication bias (Egger´s test, p=0.0029). Correcting for publication bias via the trim and fill method yielded a corrected pooled HR estimate for CSS of 1.13 (1.05–1.21; p=0.0012).

The present data demonstrate gender-specific differences in DFS, CSS and OS following radical cystectomy in bladder cancer patients. Researchers pointed out that such difference might be explained by a multifactorial aetiology that included epidemiological differences, gender-specific healthcare discrepancies and hormonal influences.

Editor's Recommendations
Most Read Articles
6 days ago
Older women with longer endogenous oestrogen exposure and hormone therapy use are at much higher odds of having favourable cognitive status in late life, a recent study suggests.
3 days ago
In patients with atrial fibrillation (AF) and stable coronary artery disease (CAD), rivaroxaban monotherapy is noninferior to combination treatment with an antiplatelet therapy in terms of cutting the risk of cardiovascular events and mortality, according to data from the AFIRE trial.
Elvira Manzano, 4 days ago
Supplementation with omega-3 fatty acids or vitamin D3 for up to 5 years has no effect on kidney function in adults with type 2 diabetes (T2D), the VITAL-DKD* ancillary study has shown.
Jairia Dela Cruz, 2 days ago
Many patients with nonvalvular atrial fibrillation (NVAF) in Thailand use anticoagulants, but the uptake of nonvitamin-K oral anticoagulants remains suboptimal despite showing an upward trend, according to data from the COOL-AF registry presented at the European Society of Cardioloy (ESC) Asia Congress 2019 with APSC and AFC.